From tactical RPGs to MMORPGs, Triumph Games is shaping Web3 titles where players own, create, and evolve the worlds they ...
Harrow plans to submit a New Drug Application (“NDA”) to the FDA in 2027, with a potential U.S. commercial launch in 2028.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback